Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Oct-22 4:43 PM View:  | Outlook Therapeutics, Inc. (OTLK) | 05-Oct-22 | Purchase | 15,662 | $1.23 | $19,264.30 | 3% 457.45K to 473.12K | |
| 05-Oct-22 4:43 PM View: | Outlook Therapeutics, Inc. (OTLK) | 04-Oct-22 | Private Purchase | 95,541 | $1.29 | $123,248.00 | 26% 361.91K to 457.45K | |
| 03-Oct-22 5:19 PM View: | Outlook Therapeutics, Inc. (OTLK) | 03-Oct-22 | Purchase | 41,798 | $1.25 | $52,247.50 | 13% 320.12K to 361.91K | |
| 03-Oct-22 5:19 PM View: | Outlook Therapeutics, Inc. (OTLK) | 30-Sep-22 | Purchase | 33,199 | $1.26 | $41,830.70 | 12% 286.92K to 320.12K | |
| 03-Oct-22 5:19 PM View: | Outlook Therapeutics, Inc. (OTLK) | 29-Sep-22 | Private Purchase | 13,800 | $1.19 | $16,422.00 | 5% 273.12K to 286.92K | |
| 03-Mar-22 5:30 PM View: | Outlook Therapeutics, Inc. (OTLK) | 01-Mar-22 | Private Purchase | 27,708 | $1.69 | $46,826.50 | 11% 245.41K to 273.12K | |
| 28-Feb-22 5:57 PM View: | Outlook Therapeutics, Inc. (OTLK) | 28-Feb-22 | Purchase | 6,000 | $1.60 | $9,600.00 | 3% 239.41K to 245.41K | |
| 28-Feb-22 5:57 PM View: | Outlook Therapeutics, Inc. (OTLK) | 24-Feb-22 | Private Purchase | 41,160 | $1.46 | $60,093.60 | 21% 198.25K to 239.41K | |
| 23-Feb-22 5:42 PM View: | Outlook Therapeutics, Inc. (OTLK) | 23-Feb-22 | Purchase | 79,535 | $1.44 | $114,530.00 | 67% 118.71K to 198.25K | |
| 23-Feb-22 5:42 PM View: | Outlook Therapeutics, Inc. (OTLK) | 22-Feb-22 | Private Purchase | 95,597 | $1.49 | $142,440.00 | 414% 23.12K to 118.71K | |
| 06-Feb-19 5:57 PM View: | Outlook Therapeutics, Inc. (OTLK) | 04-Feb-19 | Market Purchase | 5,983 | $0.80 | $4,786.40 | 3% 178.96K to 184.95K | (75%) |
| 01-Feb-19 6:25 PM View: | Outlook Therapeutics, Inc. (OTLK) | 01-Feb-19 | Market Purchase | 8,200 | $0.77 | $6,314.00 | 5% 170.76K to 178.96K | (74%) |
| 01-Feb-19 6:25 PM View: | Outlook Therapeutics, Inc. (OTLK) | 31-Jan-19 | Market Purchase | 6,300 | $0.75 | $4,725.00 | 4% 164.46K to 170.76K | (73%) |
| 01-Feb-19 6:25 PM View: | Outlook Therapeutics, Inc. (OTLK) | 30-Jan-19 | Market Purchase | 4,890 | $0.72 | $3,520.80 | 3% 159.57K to 164.46K | (72%) |
| 29-Jan-19 7:01 PM View: | Outlook Therapeutics, Inc. (OTLK) | 29-Jan-19 | Market Purchase | 5,400 | $0.73 | $3,942.00 | 4% 154.17K to 159.57K | (72%) |
| 29-Jan-19 7:01 PM View: | Outlook Therapeutics, Inc. (OTLK) | 28-Jan-19 | Market Purchase | 15,884 | $0.71 | $11,277.60 | 11% 138.29K to 154.17K | (72%) |
| 29-Jan-19 7:01 PM View: | Outlook Therapeutics, Inc. (OTLK) | 25-Jan-19 | Market Purchase | 10,828 | $0.69 | $7,471.32 | 8% 127.46K to 138.29K | (71%) |
| 24-Jan-19 7:51 PM View: | Outlook Therapeutics, Inc. (OTLK) | 23-Jan-19 | Market Purchase | 2,266 | $0.67 | $1,518.22 | 2% 125.2K to 127.46K | (70%) |
| 24-Jan-19 7:51 PM View: | Outlook Therapeutics, Inc. (OTLK) | 22-Jan-19 | Market Purchase | 10,749 | $0.68 | $7,309.32 | 9% 114.45K to 125.2K | (70%) |
| 18-Jan-19 4:51 PM View: | Outlook Therapeutics, Inc. (OTLK) | 17-Jan-19 | Market Purchase | 2,300 | $0.69 | $1,587.00 | 2% 112.15K to 114.45K | (71%) |
| 18-Jan-19 4:51 PM View: | Outlook Therapeutics, Inc. (OTLK) | 16-Jan-19 | Market Purchase | 800 | $0.68 | $544.00 | < 1% 111.35K to 112.15K | (71%) |
| 16-Jan-19 5:31 PM View: | Outlook Therapeutics, Inc. (OTLK) | 15-Jan-19 | Market Purchase | 2,266 | $0.70 | $1,586.20 | 2% 109.08K to 111.35K | (71%) |
| 16-Jan-19 5:31 PM View: | Outlook Therapeutics, Inc. (OTLK) | 14-Jan-19 | Market Purchase | 4,399 | $0.71 | $3,123.29 | 4% 104.68K to 109.08K | (72%) |
| 11-Jan-19 5:18 PM View: | Outlook Therapeutics, Inc. (OTLK) | 10-Jan-19 | Market Purchase | 6,053 | $0.70 | $4,237.10 | 6% 98.63K to 104.68K | (71%) |
| 11-Jan-19 5:18 PM View: | Outlook Therapeutics, Inc. (OTLK) | 09-Jan-19 | Market Purchase | 2,792 | $0.73 | $2,038.16 | 3% 95.84K to 98.63K | (72%) |
| 08-Jan-19 8:13 PM View: | Outlook Therapeutics, Inc. (OTLK) | 08-Jan-19 | Market Purchase | 6,410 | $0.65 | $4,166.50 | 7% 89.43K to 95.84K | (69%) |
| 08-Jan-19 8:13 PM View: | Outlook Therapeutics, Inc. (OTLK) | 07-Jan-19 | Market Purchase | 5,166 | $0.63 | $3,254.58 | 6% 84.26K to 89.43K | (68%) |
| 08-Jan-19 8:13 PM View: | Outlook Therapeutics, Inc. (OTLK) | 04-Jan-19 | Market Purchase | 6,205 | $0.59 | $3,660.95 | 8% 78.06K to 84.26K | (66%) |
| 03-Jan-19 6:01 PM View: | Outlook Therapeutics, Inc. (OTLK) | 03-Jan-19 | Market Purchase | 4,200 | $0.59 | $2,478.00 | 6% 73.86K to 78.06K | (66%) |
| 03-Jan-19 6:01 PM View: | Outlook Therapeutics, Inc. (OTLK) | 02-Jan-19 | Market Purchase | 1,640 | $0.59 | $967.60 | 2% 72.22K to 73.86K | (66%) |
| 03-Jan-19 6:01 PM View: | Outlook Therapeutics, Inc. (OTLK) | 31-Dec-18 | Market Purchase | 11,349 | $0.59 | $6,695.91 | 19% 60.87K to 72.22K | (66%) |
| 28-Dec-18 5:06 PM View: | Outlook Therapeutics, Inc. (OTLK) | 28-Dec-18 | Market Purchase | 11,910 | $0.52 | $6,193.20 | 24% 48.96K to 60.87K | (61%) |
| 28-Dec-18 5:06 PM View: | Outlook Therapeutics, Inc. (OTLK) | 27-Dec-18 | Market Purchase | 730 | $0.51 | $372.30 | 2% 48.23K to 48.96K | (61%) |
| 28-Dec-18 5:06 PM View: | Outlook Therapeutics, Inc. (OTLK) | 26-Dec-18 | Market Purchase | 5,714 | $0.54 | $3,085.56 | 13% 42.51K to 48.23K | (63%) |
| 26-Dec-18 5:17 PM View: | Outlook Therapeutics, Inc. (OTLK) | 24-Dec-18 | Market Purchase | 1,113 | $0.66 | $734.58 | 3% 41.4K to 42.51K | (70%) |
| 26-Dec-18 5:17 PM View: | Outlook Therapeutics, Inc. (OTLK) | 21-Dec-18 | Market Purchase | 3,600 | $0.65 | $2,340.00 | 10% 37.8K to 41.4K | (69%) |
| 24-Jan-17 5:44 PM View: | Outlook Therapeutics, Inc. (OTLK) | 23-Jan-17 | Exercise (in-the money or at-the-money) | 12,036 | $0.01 | $120.36 | 65% 18.52K to 30.55K | |
| 30-Nov-16 5:25 PM View: | Outlook Therapeutics, Inc. (OTLK) | 30-Nov-16 | Acquisition (other) | 6,885 | -- | -- | 59% 11.63K to 18.52K | |
| 30-Nov-16 5:25 PM View: | Outlook Therapeutics, Inc. (OTLK) | 28-Nov-16 | Acquisition (other) | 11,633 | -- | -- | 100% 0 to 11.63K | |
| 03-Jan-14 3:17 PM View: | Humana Inc. (HUM) | 31-Dec-13 | Option Exercise | 2,026 | -- | -- | 12% 17.42K to 19.45K | |
| 19-Jun-12 5:13 PM View: | Humana Inc. (HUM) | 18-Jun-12 | Payment of Exercise | 7,280 | $78.54 | $571,808.00 | (29%) 24.7K to 17.42K | (425%) |
| 19-Jun-12 5:13 PM View: | Humana Inc. (HUM) | 18-Jun-12 | Option Exercise | 17,500 | $17.40 | $304,450.00 | 243% 7.2K to 24.7K | |
| 20-Feb-07 8:25 AM View: | Amerisourcebergen Corp. (COR) | 15-Feb-07 | Grant | 10,000 | -- | -- | 6% 166.4K to 176.4K | |
| 30-Jan-07 5:36 PM View: | Amerisourcebergen Corp. (COR) | 29-Jan-07 | Option Exercise | 120,000 | $14.27 | $1,711,870.00 | 72% 166.4K to 286.4K | |
| 30-Jan-07 5:36 PM View: | Amerisourcebergen Corp. (COR) | 29-Jan-07 | Market Option Sale | 120,000 | $51.79 | $6,214,450.00 | (42%) 286.4K to 166.4K | (314%) |
| 20-Mar-06 4:59 PM View: | Amerisourcebergen Corp. (COR) | 08-Feb-06 | Grant | 10,000 | $43.45 | $434,500.00 | 6% 156.4K to 166.4K | 395% |
| 05-Dec-05 5:16 PM View: | Amerisourcebergen Corp. (COR) | 05-Dec-05 | Option Exercise | 40,000 | $24.31 | $972,500.00 | 51% 78.2K to 118.2K | |
| 05-Dec-05 5:16 PM View: | Amerisourcebergen Corp. (COR) | 05-Dec-05 | Market Option Sale | 40,000 | $80.00 | $3,200,000.00 | (34%) 118.2K to 78.2K | (438%) |
| 02-Jun-05 4:23 PM View: | Amerisourcebergen Corp. (COR) | 02-Jun-05 | Market Sale | 38,500 | $65.00 | $2,502,560.00 | (33%) 116.7K to 78.2K | (562%) |
| 05-Jan-05 10:00 AM View: | Humana Inc. (HUM) | 03-Jan-05 | Grant | 3,400 | $29.42 | $100,011.00 | 89% 3.8K to 7.2K | 1272% |